Armata Pharmaceuticals (ARMP) Cash from Investing Activities Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -674.01% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -166.24% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -122.45% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 36.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.36% |
| Dec 31, 2025 | -167.53% |
| Sep 30, 2025 | 28.82% |
| Jun 30, 2025 | 89.09% |
| Mar 31, 2025 | 60.40% |
| Dec 31, 2024 | 103.22% |
| Sep 30, 2024 | 90.32% |
| Jun 30, 2024 | -515.32% |
| Mar 31, 2024 | 87.56% |
| Dec 31, 2023 | -625.27% |
| Sep 30, 2023 | -171.41% |
| Jun 30, 2023 | 80.46% |
| Mar 31, 2023 | -751.69% |
| Dec 31, 2022 | 299.56% |
| Sep 30, 2022 | -122.34% |
| Jun 30, 2022 | -479.59% |
| Mar 31, 2022 | 20.81% |
| Dec 31, 2021 | 37.70% |
| Sep 30, 2021 | -618.52% |
| Jun 30, 2021 | 28.21% |
| Mar 31, 2021 | -186.54% |
| Dec 31, 2020 | -608.33% |
| Sep 30, 2020 | -224.62% |
| Jun 30, 2020 | -109.47% |
| Mar 31, 2020 | 26.76% |
| Dec 31, 2019 | 113.46% |
| Sep 30, 2019 | 690.91% |
| Dec 31, 2018 | -2,872.22% |
| Sep 30, 2018 | 66.67% |
| Dec 31, 2017 | -38.46% |
| Sep 30, 2017 | -13.79% |
| Jun 30, 2017 | 98.40% |
| Mar 31, 2017 | 95.54% |
| Dec 31, 2016 | 74.00% |
| Sep 30, 2016 | 75.00% |
| Jun 30, 2016 | -1,288.89% |